UBS AM’s Relmada Therapeutics RLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-22,671
| Closed | -$839K | – | 2717 |
|
|
2022
Q3 | $839K | Buy |
22,671
+9,142
| +68% | +$338K | ﹤0.01% | 2069 |
|
|
2022
Q2 | $257K | Sell |
13,529
-10,591
| -44% | -$201K | ﹤0.01% | 2514 |
|
|
2022
Q1 | $651K | Buy |
+24,120
| New | +$651K | ﹤0.01% | 2357 |
|
|
2021
Q3 | – | Sell |
-7,358
| Closed | -$236K | – | 2770 |
|
|
2021
Q2 | $236K | Buy |
7,358
+958
| +15% | +$30.7K | ﹤0.01% | 2691 |
|
|
2021
Q1 | $225K | Hold |
6,400
| – | – | ﹤0.01% | 2543 |
|
|
2020
Q4 | $205K | Sell |
6,400
-5,500
| -46% | -$176K | ﹤0.01% | 2495 |
|
|
2020
Q3 | $448K | Buy |
11,900
+6,400
| +116% | +$241K | ﹤0.01% | 2188 |
|
|
2020
Q2 | $246K | Buy |
+5,500
| New | +$246K | ﹤0.01% | 2337 |
|